transmedТрансляционная медицинаTranslational Medicine2311-44952410-5155Almazov National Medical Research Centre, Saint Petersburg, Russia10.18705/2311-4495-2014-0-4-46-50transmed-50Research ArticleАКУШЕРСТВО И ГИНЕКОЛОГИЯВЛИЯНИЕ ПРЕЭКЛАМПСИИ НА ФИЗИОЛОГИЧЕСКИЕ И ПАТОЛОГИЧЕСКИЕ ПРОЦЕССЫ В СОСУДАХ И РИСКИ РАЗВИТИЯ СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ ПОСЛЕ РОДОВINFLUENCE OF PREECLAMPSIA INTO PHYSIOLOGICAL AND PATHOLOGICAL PROCESSES IN THE VESSELS AND THE RISK OF HEART DISEASE AFTER BIRTHРябоконьНикита РомановичRyabokonNikita R.n-i-k-o-n@mail.ruКузнецоваЛюбовь ВладимировнаKuznetsovaL. V.noemail@neicon.ruЗазерскаяИрина ЕвгеньевнаZazerskayaI. E.zazera@mail.ruФГБУ «Федеральный медицинский исследовательский центр им. В.А. Алмазова» Минздрава РоссииРоссияFederal Almazov Medical Research CentreRussian Federation201423122016044650Copyright © Рябоконь Н.Р., Кузнецова Л.В., Зазерская И.Е., 20162016Рябоконь Н.Р., Кузнецова Л.В., Зазерская И.Е.Ryabokon N.R., Kuznetsova L.V., Zazerskaya I.E.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://transmed.almazovcentre.ru/jour/article/view/50

В настоящем обзоре представлены современные представления о функции сосудов, методиках оценки сосудистой стенки, адаптивных изменений, протекающих в ней на протяжении физиологической беременности и преэклампсии. Особое внимание уделено характерным изменениям сердечно-сосудистой системы, происходящим на фоне преэклампсии, а также поиску оптимально подходящего метода оценки сосудов при беременности и его прогностической ценности.

This review summarizes current understanding of the function of blood vessels, valuation methodologies the vascular wall, the adaptive changes that occur in it during normal pregnancy.

оценка жесткости сосудовсосудистая стенкафизиологическая беременностьпреэклампсияпульсовая волнаevaluation of the stiffness of blood vesselsvascular wallthe physiological pregnancypreeclampsiapulse waveReferencesMayhew T.M. Fetoplacental angiogenesis during gestation is biphasic, longitudinal and occurs by proliferation and remodeling of vascular endothelial cells // Placenta. - 2002. - Vol. 23. - P. 742-750.Mayhew T.M. Fetoplacental angiogenesis during gestation is biphasic, longitudinal and occurs by proliferation and remodeling of vascular endothelial cells // Placenta. - 2002. - Vol. 23. - P. 742-750.Jaffe R., Jauniaux E., Hustin J. Maternal circulation in the first-trimester human placenta - myth or reality? // Am. J. Obstet. Gynecol. - 1997. - Vol. 176, № 3. - P. 699-705.Jaffe R., Jauniaux E., Hustin J. Maternal circulation in the first-trimester human placenta - myth or reality? // Am. J. Obstet. Gynecol. - 1997. - Vol. 176, № 3. - P. 699-705.Risau W., Flamme I. Vasculogenesis // Ann. Rev. Cell. Dev. Biol. - 2005. - Vol. 11. - P. 73-91.Risau W., Flamme I. Vasculogenesis // Ann. Rev. Cell. Dev. Biol. - 2005. - Vol. 11. - P. 73-91.Charnock-Jones D.S., Kaufmann P., Mayhew T.M. Aspects of human fetoplacental vasculogenesis and angiogenesis I. Molecular regulation // Placenta. - 2004. - Vol. 25, № 2-3. - P. 103-113.Charnock-Jones D.S., Kaufmann P., Mayhew T.M. Aspects of human fetoplacental vasculogenesis and angiogenesis I. Molecular regulation // Placenta. - 2004. - Vol. 25, № 2-3. - P. 103-113.Никитина Л.А., Демидова Е.И., Радзинский В.Е. и др. Роль матриксных белков, цитокинов и факторов ангиогенеза маточно-плацентарного комплекса в регуляции имплантации и плацентации // Акушерство и гинекология. - 2007. - Т. 3. - С. 5-10.Никитина Л.А., Демидова Е.И., Радзинский В.Е. и др. Роль матриксных белков, цитокинов и факторов ангиогенеза маточно-плацентарного комплекса в регуляции имплантации и плацентации // Акушерство и гинекология. - 2007. - Т. 3. - С. 5-10.Yancopoulos G.D., Davis S., Gale N.W. et al. Vascular-specific growth factors and blood vessel formation // Nature. - 2000. - Vol. 407, № 6801. - P. 242-248.Yancopoulos G.D., Davis S., Gale N.W. et al. Vascular-specific growth factors and blood vessel formation // Nature. - 2000. - Vol. 407, № 6801. - P. 242-248.Smith S.K. Angiogenesis and reproduction // Br. J. Obstetr. and Gyn. - 2001. - Vol. 108. - P. 777-783.Smith S.K. Angiogenesis and reproduction // Br. J. Obstetr. and Gyn. - 2001. - Vol. 108. - P. 777-783.Ferrara N. Vascular endothelial growth factor: basic science and clinical progress // Endocrin. Rev. - 2004. - Vol. 25. - P. 581-611.Ferrara N. Vascular endothelial growth factor: basic science and clinical progress // Endocrin. Rev. - 2004. - Vol. 25. - P. 581-611.Naldini A., Carraro F. Role of inflammatory mediators in angiogenesis // Curr. Drug Targets Inflamm. Allergy. - 2005. - Vol. 4. - P. 3-18.Naldini A., Carraro F. Role of inflammatory mediators in angiogenesis // Curr. Drug Targets Inflamm. Allergy. - 2005. - Vol. 4. - P. 3-18.Hanna J., Goldman-Wohl D., Hamani Y. et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. - Nat. Med. - 2006. - Vol. 12. - P. 1065-1074.Hanna J., Goldman-Wohl D., Hamani Y. et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. - Nat. Med. - 2006. - Vol. 12. - P. 1065-1074.Hayashi T., Matsuoka K., Saitoh M. et al. Influence of alpha-tumor necrosis factor and beta-interleukin-1 on production of angiogenetic factors and thymidine phosphorylase activity in immortalized human decidual fibroblasts in vitro // J. Obstet. Gynaecol. - 2006. - Vol. 32. - P. 15-22.Hayashi T., Matsuoka K., Saitoh M. et al. Influence of alpha-tumor necrosis factor and beta-interleukin-1 on production of angiogenetic factors and thymidine phosphorylase activity in immortalized human decidual fibroblasts in vitro // J. Obstet. Gynaecol. - 2006. - Vol. 32. - P. 15-22.Beck Jr. L., D’Amore P.A. Vascular development: cellular and molecular regulation. - FASEB. J. - 2011. - Vol. 11. - P. 365-373.Beck Jr. L., D’Amore P.A. Vascular development: cellular and molecular regulation. - FASEB. J. - 2011. - Vol. 11. - P. 365-373.Ortega N., L’Faqihi F.E., Plouet J. Control of vascular endothelial growth factor angiogenic activity by the extracellular matrix // Biol Cell. - 1998. - Vol. 90. - P. 381-390.Ortega N., L’Faqihi F.E., Plouet J. Control of vascular endothelial growth factor angiogenic activity by the extracellular matrix // Biol Cell. - 1998. - Vol. 90. - P. 381-390.Breier G., Damert A., Plate K.H., Risau W. Angiogenesis in embryos and ischemic diseases // Thromb. Haemost. - 2007. - Vol. 78. - P. 678-683.Breier G., Damert A., Plate K.H., Risau W. Angiogenesis in embryos and ischemic diseases // Thromb. Haemost. - 2007. - Vol. 78. - P. 678-683.Shalaby F., Rossant J., Yamaguchi T.P. et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice // Nature. - 1995. - Vol. 376. - P. 62-66.Shalaby F., Rossant J., Yamaguchi T.P. et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice // Nature. - 1995. - Vol. 376. - P. 62-66.Zhou Y., Fisher S.J., Janatpour M. et al. Human cytot-rophoblasts adopt a vascular phenotype as they differentiate: a strategy for successful endovascular invasion? // J. Clin. Invest. - 2007. - Vol. 99. - P. 2139-2151.Zhou Y., Fisher S.J., Janatpour M. et al. Human cytot-rophoblasts adopt a vascular phenotype as they differentiate: a strategy for successful endovascular invasion? // J. Clin. Invest. - 2007. - Vol. 99. - P. 2139-2151.Roberts J.M. Endothelial dysfunction in preeclampsia // Sem. Reprod. Endocrinol. - 2008. - Vol.16. - P. 5-15.Roberts J.M. Endothelial dysfunction in preeclampsia // Sem. Reprod. Endocrinol. - 2008. - Vol.16. - P. 5-15.Johnston R.W. Toxaemias of pregnancy. A Textbook of Midwifery. - London: A&C Black, 1989. - P. 237-259.Johnston R.W. Toxaemias of pregnancy. A Textbook of Midwifery. - London: A&C Black, 1989. - P. 237-259.Baker P.N., Krasnow J., Roberts J.M. et al. Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia // Obstet. Gynecol. - 2005. - Vol. 86. - P. 815-821.Baker P.N., Krasnow J., Roberts J.M. et al. Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia // Obstet. Gynecol. - 2005. - Vol. 86. - P. 815-821.Sharkey A.M., Cooper J.C., Balmforth J.R. et al. Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies-complicated by pre-eclampsia // Europ. J. Clin. Investig. - 2006. - Vol. 26. - P. 1182-1185.Sharkey A.M., Cooper J.C., Balmforth J.R. et al. Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies-complicated by pre-eclampsia // Europ. J. Clin. Investig. - 2006. - Vol. 26. - P. 1182-1185.Brockelsby J., Hayman R., Ahmed A. et al. VEGF via VEGF receptor-1 (Flt-1) mimics preeclamptic plasma in inhibiting uterine blood vessel relaxation in pregnancy: implications in the pathogenesis of preeclampsia // Lab. Invest. - 2009. - Vol. 79. - P. 1101-1111.Brockelsby J., Hayman R., Ahmed A. et al. VEGF via VEGF receptor-1 (Flt-1) mimics preeclamptic plasma in inhibiting uterine blood vessel relaxation in pregnancy: implications in the pathogenesis of preeclampsia // Lab. Invest. - 2009. - Vol. 79. - P. 1101-1111.Torry D.S., Wang H.S., Wang T.H., et al. Preeclampsia is associated with reduced serum levels of placenta growth factor // Am. J. Obstet. Gynecol. - 2009. - Vol. 179. - P. 1539-1544.Torry D.S., Wang H.S., Wang T.H., et al. Preeclampsia is associated with reduced serum levels of placenta growth factor // Am. J. Obstet. Gynecol. - 2009. - Vol. 179. - P. 1539-1544.Duckitt K., Harrington D. Risk factors for preeclampsia at antenatal booking: systematic review of controlled studies. - BMJ. - 2005. - Vol. 330. - P. 565.Duckitt K., Harrington D. Risk factors for preeclampsia at antenatal booking: systematic review of controlled studies. - BMJ. - 2005. - Vol. 330. - P. 565.Cnattingius S., Reilly M., Pawitan Y., et al. Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: a population-based Swedish cohort study // Am. J. Med. Genet. - 2004. - Vol. 130A. - P. 365-371.Cnattingius S., Reilly M., Pawitan Y., et al. Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: a population-based Swedish cohort study // Am. J. Med. Genet. - 2004. - Vol. 130A. - P. 365-371.Nilsson E., Salonen R.H., Cnattingius S. et al. The importance of genetic and environmental effects for preeclampsia and gestational hypertension: a family study. - BJOG. - 2004. - Vol. 111. - P. 200-206.Nilsson E., Salonen R.H., Cnattingius S. et al. The importance of genetic and environmental effects for preeclampsia and gestational hypertension: a family study. - BJOG. - 2004. - Vol. 111. - P. 200-206.Haukkamaa L., Moilanen L., Kattainen A. et al. Pre-eclampsia is a risk factor of carotid artery atherosclerosis // Cerebrovasc. Dis. - 2009. - Vol. 27. - P. 599-607.Haukkamaa L., Moilanen L., Kattainen A. et al. Pre-eclampsia is a risk factor of carotid artery atherosclerosis // Cerebrovasc. Dis. - 2009. - Vol. 27. - P. 599-607.Versen-Hoeynck F.M., Hubel C.A., Gallaher M.J. et al. Plasma levels of inflammatory markers neopterin, sialic acid, and C-reactive protein in pregnancy and preeclampsia // Am. J. Hypertens. - 2009. - Vol. 22. - P. 687-692.Versen-Hoeynck F.M., Hubel C.A., Gallaher M.J. et al. Plasma levels of inflammatory markers neopterin, sialic acid, and C-reactive protein in pregnancy and preeclampsia // Am. J. Hypertens. - 2009. - Vol. 22. - P. 687-692.Jantos-Siwy J., Schiffer E., Brand K. et al. Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease // J. Proteome Res. - 2009. - Vol. 8. - P. 268-281.Jantos-Siwy J., Schiffer E., Brand K. et al. Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease // J. Proteome Res. - 2009. - Vol. 8. - P. 268-281.Verlohren S., Galindo A., Schlembach D. et al. An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia // Am. J. Obstet. Gynecol. - 2010. - Vol. 202. - P. 161.Verlohren S., Galindo A., Schlembach D. et al. An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia // Am. J. Obstet. Gynecol. - 2010. - Vol. 202. - P. 161.Mitchell G.F. et al. Arterial swiftness and cardiovascular events, the Framingham Heart Study. Circulation - 2010. - Vol. 121, № 4. - P. 505-11 2010Mitchell G.F. et al. Arterial swiftness and cardiovascular events, the Framingham Heart Study. Circulation - 2010. - Vol. 121, № 4. - P. 505-11 2010O’Rourke M.F., et. al. The pulse of cardiologyl // Journal of American college of cardiology - 2009. - Vol. 54. - P. 714-717O’Rourke M.F., et. al. The pulse of cardiologyl // Journal of American college of cardiology - 2009. - Vol. 54. - P. 714-717Кобалава Ж.Д., и др. Проблемы взаимодействия врача и пациента и контроль артериальной гипертонии в России // Кардиология - 2007. - Vol. 3. - С. 38-47.Кобалава Ж.Д., и др. Проблемы взаимодействия врача и пациента и контроль артериальной гипертонии в России // Кардиология - 2007. - Vol. 3. - С. 38-47.

The authors declare that there are no conflicts of interest present.